Clinical Trial Update: Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating the safety, efficacy, and cellular metabolic dynamics of ct1192 in adults with moderate to severe refractory systemic lup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CT1192

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 1 | Status: RECRUITING